Cargando…

Transgenic models are predictive: the herceptin and flavopiridol experience

Detalles Bibliográficos
Autor principal:	Schmidt, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300148/ http://dx.doi.org/10.1186/bcr687

Ejemplares similares

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Herceptin in clinical use - early 2000
por: Vogel, CL
Publicado: (2000)

Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
por: Slamon, DJ
Publicado: (2000)

Effect of P-glycoprotein on flavopiridol sensitivity
por: Boerner, S A, et al.
Publicado: (2001)

Assessing ectomycorrhizal associations and transgene expression in transgenic Castanea dentata
por: D'Amico, Katherine, et al.
Publicado: (2011)

Reversibility and progression in conditional transgenic mouse models of breast cancer
por: Chodosh, LA, et al.
Publicado: (2003)

Potent interaction of flavopiridol with MRP1
por: Hooijberg, J H, et al.
Publicado: (1999)

The Pharmacological Implications of Flavopiridol: An Updated Overview
por: Joshi, Hemant, et al.
Publicado: (2023)

Expression of aquaporins in a transgenic mouse model of Alzheimer's disease
por: Chan, Sic L, et al.
Publicado: (2010)

Functional dissection of the cGK substrate IRAG using transgenic models
por: Schlossmann, Jens, et al.
Publicado: (2009)

Integrin-mediated signal transduction in transgenic mouse models of human breast cancer
por: White, DE, et al.
Publicado: (2003)

The mouse in preclinical trials: transgenic, carcinogen-induced, or xenograph models – which to use?
por: Brown, P
Publicado: (2003)

Transgenic livestock for agriculture and biomedical applications
por: Long, Charles
Publicado: (2014)

Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition
por: Ni, Wenjun, et al.
Publicado: (2010)

Delineation of anthracyclines and herceptin induced cardiotoxicity using contrast enhanced CMR
por: Hamirani, Yasmin S, et al.
Publicado: (2014)

A transgenic Drosophila melanogaster model to study HTLV-I oncoprotein Tax-driven leukemogenesis in vivo
por: Shirinian, Margret, et al.
Publicado: (2015)

Complex effects of flavopiridol on the expression of primary response genes
por: Keskin, Havva, et al.
Publicado: (2012)

Mycorrhization of transgenic apple trees with increased resistance against fungal pathogens
por: Schäfer, Tina, et al.
Publicado: (2011)

Introduction of alkali-labile units into lignin in transgenic plants by genetic engineering
por: Ishikawa, Yasuyuki, et al.
Publicado: (2011)

Project Aedes transgenic population control in Juazeiro and Jacobina Bahia, Brazil
por: Malavasi, Aldo
Publicado: (2014)

Transgenic animal models for the production of human immunocompounds in milk to prevent diarrhea, malnourishment and child mortality: perspectives for the Brazilian Semi-Arid region
por: Bertolini, Luciana, et al.
Publicado: (2014)

Development of a transgenic mouse line for the evaluation of the androgen receptor activity in vivo
por: Attar, R, et al.
Publicado: (2003)

Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin
por: Trojanec, R, et al.
Publicado: (2011)

Greenhouse and field evaluation of transgenic poplars with modified gibberellin metabolism and signaling genes
por: Viswanath, Venkatesh, et al.
Publicado: (2011)

A brief overview of field testing and commercial application of transgenic trees in China
por: Lu, Meng-Zhu, et al.
Publicado: (2011)

Construction of transgene-amplified CHO cell lines by cell cycle checkpoint engineering
por: Lee, Kyoung Ho, et al.
Publicado: (2013)

Psoriasis Induced by Trastuzumab (Herceptin®)
por: Kim, Dae Hun, et al.
Publicado: (2013)

Differential effects on HIV replication and T cell activation following direct inhibition of CDK9 or flavopiridol (FVP) treatment in primary peripheral blood lymphocytes
por: Salerno, D, et al.
Publicado: (2006)

7.1 Transgenic overexpression of CREM alpha in murine T cells results in an anergic phenotype with enhanced IL17 production
por: Lippe, RL, et al.
Publicado: (2008)

Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
por: Harmening, Kathrin, et al.
Publicado: (2009)

Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
por: Hu, Zi’ang, et al.
Publicado: (2018)

The role of Herceptin in early breast cancer
por: Subramanian, Ashok, et al.
Publicado: (2008)

Mild hyperthermia influence on Herceptin(®) properties
por: Escoffre, Jean-Michel, et al.
Publicado: (2015)

Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen
por: Cimica, Velasco, et al.
Publicado: (2010)

Transgenic expression of Notch-1 intracellular active domain (N1IC) in T cells: a potential therapy to overcome suppression induced by tumors
por: Sierra, Rosa A, et al.
Publicado: (2013)

A neurocomputational model of temporal processing: evidence from sequence experiments
por: Hass, Joachim, et al.
Publicado: (2007)

The role of systems modeling in drug discovery and predictive health
por: Voit, Eberhard O
Publicado: (2010)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

Prediction of recurrent stroke and myocardial infarction after stroke: a systematic review of clinical prediction models
por: Thompson, Douglas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9m4jqqjj48oi4210scnpnlqtk2